Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - July 13, 2022 Category: Cancer & Oncology Authors: Chuan Jin Arwa Ali Alexandros Iskantar Grammatiki Fotaki Hai Wang Magnus Essand Alex Karlsson-Parra Di Yu Source Type: research